Caffeine ameliorates high energy diet-induced hepatic steatosis: sirtuin 3 acts as a bridge in the lipid metabolism pathway. (Q50441886)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

Caffeine ameliorates high energy diet-induced hepatic steatosis: sirtuin 3 acts as a bridge in the lipid metabolism pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Rong-Rong He

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Shi-Jie Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Yi-Fang Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Guo-En Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Rui-Rong Tan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Gao-Wei Mao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Yu-Jia Zhai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ling-Fang Cao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Min Chen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hiroshi Kurihara

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Qi Wang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

26 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

2578-2587

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet.

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Caffeine is protective in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Genistein promotes insulin action through adenosine monophosphate-activated protein kinase activation and p70 ribosomal protein S6 kinase 1 inhibition in the skeletal muscle of mice fed a high energy diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Differential effects of chow and purified diet on the consumption of sucrose solution and lard and the development of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Caffeine suppresses TNF-alpha production via activation of the cyclic AMP/protein kinase A pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Dose translation from animal to human studies revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Caffeine as a psychomotor stimulant: mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Calcium signaling in neurons: molecular mechanisms and cellular consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Regulation of camp-inducible genes by creb

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

CREB regulates hepatic gluconeogenesis through the coactivator PGC-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Peroxisome proliferator-activated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Gly482Ser mutation impairs the effects of peroxisome proliferator-activated receptor γ coactivator-1α on decreasing fat deposition and stimulating phosphoenolpyruvate carboxykinase expression in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Sirtuins regulate key aspects of lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Mammalian sirtuins and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human HepG2 cells and obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00247H

21 January 2018

Identifiers

DOI

10.1039/C5FO00247H

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26114447%20AND%20SRC:MED&resulttype=core&format=json